In a select sample of breast cancer patients, the possible anti-cancer effects of metformin do not significantly increase survival rates….
Read More »Diabetic Emergencies, Diagnosis and Clinical Management: Hyperosmolar Non-ketotic Hyperglycemia, Part 4
Konstantinos Makrilakis, MD, PhD Nikolaos Katsilambros, MD, PhD. Avoidance of complications Hypoglycemia and hypokalemia are the two most common complications of treatment of hyperglycemic crises with insulin. They have both been reduced significantly, however, with the administration of low-dose insulin and careful monitoring and replacement of serum potassium. 27,28 Frequent …
Read More »Core Defects of Type 2 Diabetes, Part 3 of 4
With this week’s Homerun Slides, we pick up again on our Core Defects of Type 2 Diabetes series with Part 3. This set delves into the Targeting Mechanisms for a Comprehensive Approach, Complementary Mechanisms of Action, with a focus on sitagliptin…
Read More »The Smart Pill Bottle
The Smart Pill Bottle AdhereTech has created patented cloud-connected pill bottles that improve medication adherence. These bottles measure the exact number of pills or liquid in the bottle in real-time, wirelessly send this HIPAA-compliant data into the cloud, and remind patients to take their medication via phone call or text. …
Read More »Mortality Risk in Patients with Type 2 Diabetes
New predictive model for all-cause mortality in patients with type 2 diabetes….
Read More »Diabetes Epidemic Growing
Prevalence of diabetes among US adults has grown by 45% over the past 20 years….
Read More »Sleeping-in Associated with Poor Glycemic Control
Each hour delay in mid-point sleep on free days was associated with a higher HbA1c of 2.5%….
Read More »Co-Q10 May Offset Risk of Diabetes with Statin Use
Relative intensity of GLUT4 protein was decreased by 36% in simvastatin-treated adipocytes….
Read More »NHANES: Marijuana May Have Beneficial Effects for Glucose Control
The National Health and Nutrition Survey found a positive association between use of marijuana and reduced insulin resistance….
Read More »Natural GLP-1 Not Impaired in Patients with Type 2 Diabetes
A recent meta-analysis has shown that patients with type 2 diabetes (T2DM) may not have impaired secretion of glucagon-like peptide-1 (GLP-1)…. The study conducted by researchers at Gentofte Hospital at the University of Copenhagen, revealed that T2DM patients had similar levels of GLP-1 secretion as controls after an oral glucose …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.